After a sharp sell-off last week, which analysts said was sentiment-driven since US tariffs target branded and patented drugs while Indian exports are largely generic, pharma stocks recovered.
Out of the 20 index stocks, 15 advanced, led by Sun Pharma, Lupin, Cipla, Zydus Life, Biocon, Granules India, Torrent Pharma, Laurus Labs, Aurobindo Pharma, and Glenmark Pharma, which gained up to 2 percent.
The sell-off was triggered by US President Donald Trump’s announcement of 100 percent tariffs on branded and patented drugs starting October 1, part of its broader push to onshore pharma manufacturing, create jobs, and cut foreign reliance.
Also Read: Sensex rises 200 pts, Nifty above 24,700 after 6-day slide